SynCore Biotechnology Co., Ltd.

SynCore Biotechnology Co., Ltd. financial statements

SynCore Biotechnology Co., Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueTWD 27.04MEODHD
Net income−TWD 45.76MEODHD
Cash and equivalentsTWD 157.33MEODHD

SynCore Biotechnology Co., Ltd. financials on 6ix · SynCore Biotechnology Co., Ltd. on 6ix